Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis
In conclusion, S1P modulators represent a novel and promising therapeutic strategy for immune-mediated diseases.
Source: Drugs - Category: Drugs & Pharmacology Source Type: research
More News: Anemia | Arthritis | Cardiology | Cardiovascular | Clinical Trials | COVID-19 | Drugs & Pharmacology | Gilenya | Heart | Inflammatory Bowel Disease | Lupus | Multiple Sclerosis | Psoriasis | Rheumatoid Arthritis | Rheumatology | Study